Power Law company profile

Rhythm Pharmaceuticals

Biotech & Life Sciences · Boston, United States · Founded 2008 · IPO 2017 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$5.35B

Market cap · Apr/2026

Revenue

$194M

Latest reported FY

Investors

8 investors on Rhythm Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 8 investors entered at this stage

Global footprint

Web traffic by country

28K monthly visits
across markets

🇺🇸 United States65%

🇮🇳 India13.2%

🇨🇦 Canada6.1%

🇬🇧 United Kingdom5.7%

🇯🇵 Japan4.6%

Top 5 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo